ECigIntelligence

Regulatory and market intelligence for the e-cigarette sector

Regulatory briefing

Reynolds asks FDA to give Camel Snus products ‘modified risk’ status

Written by || 19th December 2017 || Regulatory briefing || Companies | Marketing and Retailing | Regulation and Legislation | North America United States

R. J. Reynolds has submitted modified risk tobacco product applications (MRTPAs) to the US FDA for six forms of its Camel Snus product, which it is seeking to market as reducing the risk of specific smoking-related diseases ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Related contents

FDA rejects snus as modified risk – but could reconsider some aspects
PMTA and MRTP: navigating the path to FDA approval for reduced-risk products
The way ahead: Big Tobacco looks to a smoke-free next generation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions